Outlook Therapeutics, Inc.OTLKNASDAQ
Loading
EBITDA as a percentage of revenue
Latest
-29422.36%
↓ 718% vs avg
Percentile
P0
Near historical low
Streak
2 yr
Consecutive declineContracting
Average
-3595.74%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | -29422.36% | -554.2% |
| 2025 | -4497.70% | - |
| 2024 | 0.00% | - |
| 2023 | 0.00% | - |
| 2022 | 0.00% | - |
| 2021 | 0.00% | - |
| 2020 | 0.00% | +100.0% |
| 2019 | -381.86% | +56.0% |
| 2018 | -867.71% | -10.1% |
| 2017 | -787.78% | - |